Kihealth Wins Innovation of the Year at ADA 85th Scientific Sessions for Groundbreaking Diabetes Diagnostic
SAINT AUGUSTINE, Fla. — Kihealth, a leader in molecular diagnostics, today announced it has won the Innovation of the Year challenge at the American Diabetes Association's 85 th Scientific Session held in Chicago. Kihealth's pioneering liquid-biopsy test, which measures the rate of pancreatic beta‑cell death, earned top honors among five finalists for its potential to revolutionize early diabetes detection.
Article content
Dubbed the 'Super Bowl of diabetes innovation,' this prestigious award has firmly established Kihealth and its products in the spotlight. The honor follows a live pitch to a panel of expert judges and a global audience of clinicians, researchers, and industry leaders. In winning first place, Kihealth stood out for delivering a novel diagnostic that provides patients and clinicians with a critical early window into metabolic health – years before glucose or A1c abnormalities appear prnewswire.com.
Article content
Key Highlights & Immediate Impact
Article content
Surge in physician engagement: Following the win, Kihealth has received new contracts and strong interest from healthcare providers nationwide.
Increased funding & partnerships: The recognition triggered follow-up discussions with institutional payers and wellness platforms exploring early-risk screening.
Product visibility & credibility: The award signals clear validation of Kihealth's molecular assay and commitment to elevating standards of preventive care.
Article content
'This is a monumental milestone,' said Jennifer Anderson, CEO of Kihealth. 'Winning ADA's Innovation of the Year at the 85th Scientific Sessions is the ultimate validation of our mission to enable earlier, more actionable insights into disease risk. It's sparked tremendous momentum—from physician interest and contract discussions to expanded visibility. We're just getting started.'
Article content
About Kihealth
Article content
Founded in 2023 in Florida, Kihealth is revolutionizing preventative diagnostics through ddPCR-based tests that detect metabolic and autoimmune disease risk years before traditional methods. Their flagship assay harnesses cell‑free DNA and epigenetic markers unique to beta cells. Kihealth's platform is designed for seamless integration into telehealth, employer wellness programs, clinical trials and clinical care pathways, bridging science and accessibility to redefine preventive health.
Article content
Article content
Article content
Article content
Contacts
Article content
Media Contact:
Article content
Article content
Kihealth
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
14 hours ago
- CTV News
U.S. hospital says it never agreed to deactivate inmate's heart device before execution
This undated booking photo provided by the Tennessee Department of Corrections shows Byron Black. (Tennessee Department of Corrections via AP, File) NASHVILLE, Tenn. — A Tennessee hospital says it never agreed to a request by state officials who face a court order to turn off a death row inmate's heart-regulating implant before his execution next week. After a Nashville judge ordered the deactivation of Byron Black's device, a Tennessee Department of Correction official said in a court declaration that Nashville General Hospital told her they could disable it the day before his Aug. 5 execution at 10 a.m., but wouldn't come to the prison on execution day, as the judge had ordered. The judge ultimately allowed some leniency, saying Black could be moved to the hospital the morning of the execution. But on Wednesday, Nashville General Hospital spokesperson Cathy Poole said the medical center did not agree to participate at all, saying the hospital 'has no role in State executions.' The statement adds a significant complication to the court case, which relied on the state's comment about Nashville General's expected involvement. The order is under appeal, as the days dwindle before the execution. Black's attorneys say his heart device would continuously shock him in an attempt to restore his heart's normal rhythm due to the lethal injection of pentobarbital, but the state disputes that and argues that even if shocks were triggered, that Black wouldn't feel them. WPLN-FM first reported on the statement from the hospital, which said, 'Earlier reports of Nashville General Hospital's involvement are inaccurate.' 'The correctional healthcare provider contracted by the Tennessee Department of Correction (TDOC), did not contact appropriate Nashville General Hospital leadership with its request to deactivate the implanted defibrillator,' Poole said. 'Any assertion the hospital would participate in the procedure was premature. 'Our contract with the correctional healthcare provider is to support the ongoing medical care of its patients,' Poole continued. 'This request is well outside of that agreement and would also require cooperation with several other entities, all of which have indicated they are unwilling to participate.' A spokesperson for the state Department of Correction referred a request for comment to the attorney general's office, which did not immediately respond. Kelley Henry, an attorney for Black, said, 'TDOC has mishandled this situation from the beginning. My hope is that the Governor will issue a reprieve to avoid a gruesome spectacle.' Black's final appeals for a reprieve are pending in state and federal courts, and through a clemency request with GOP Gov. Bill Lee. They also include an intellectual disability claim. The state has since sought to overturn the order to deactivate Black's implantable cardioverter-defibrillator, including when and where to do it. The state Supreme Court is considering the request. The state has said the lower-court judge lacked authority to order the device disabled. The state also says the order to transport Black to the hospital the morning of the execution presents a 'very real risk of danger to TDOC personnel, hospital patients/staff, the public, and even Black,' mentioning protesters. It's about 7 miles (11 kilometers) from Riverbend Maximum Security Institution to Nashville General Hospital. Henry, Black's attorney, said the state presented 'zero evidence of security risk,' including from the frail, 69-year-old Black or the pacifists who protest executions by prayer. Henry also said state officials had not really tried to find a doctor willing to come to the prison. Black was convicted in the 1988 shooting deaths of his girlfriend Angela Clay, 29, and her two daughters, Latoya, 9, and Lakeisha, 6. Prosecutors said he was in a jealous rage when he shot the three at their home. At the time, Black was on work-release while serving time for shooting and wounding Clay's estranged husband. Black's motion related to his heart device came within a general challenge he and other death row inmates filed against the state's new execution protocol. The trial isn't until 2026. The heart device issue also has been a reminder that most medical professionals consider participation in executions a violation of medical ethics. Dan Mann, a talent booking agent and death penalty opponent who has visited Tennessee's death row for years, wrote a letter to Nashville Mayor Freddie O'Connell and metro councilmembers calling for a resolution against the city's hospital participating in pre-execution procedure. The hospital is governed by a metro Nashville authority, with board members picked by the mayor. Jonathan Mattise, The Associated Press
Globe and Mail
14 hours ago
- Globe and Mail
Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
Johnson & Johnson (NYSE: JNJ) will present at the Morgan Stanley 23 rd Annual Global Healthcare Conference on Wednesday, September 10 th, 2025. Management will participate in a Fireside Chat at 11:30 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at An archived edition of the session will be available later that day. The audio webcast replay will be available approximately 48 hours after the webcast.
CTV News
17 hours ago
- CTV News
Diabetes Canada calls for federal government to reset pharmacare program
This Jan. 3, 2009 file photo shows a person with diabetes testing his blood sugar level in Kamen, Germany. (AP Photo/Joerg Sarbach, File) OTTAWA — Advocates for people with diabetes want the federal government to restructure what they see as a flawed pharmacare program. Glenn Thibeault, executive director of government affairs with Diabetes Canada, says the new government has an opportunity to make improvements. The previous Trudeau government budgeted $1.5 billion over five years for the first phase of pharmacare, which covers the cost of some diabetes medications and contraceptives for patients. That government signed deals with B.C., P.E.I., Manitoba and Yukon that account for more than 60 per cent of the money that's set aside. The Carney government is not committing to signing the remaining nine funding deals, saying that it's working with the provinces and territories to support them. Thibeault says Diabetes Canada wants to see more medications covered and says future deals could target coverage for people who don't have private insurance. This report by The Canadian Press was first published July 30, 2025. Sarah Ritchie, The Canadian Press
